Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Upper gastrointestinal tract bleeding caused by a gastrointestinal stromal tumor of the stomach: a case report.

The Gulf journal of oncology·2010

Same author

Abscess of the abdominal wall resulting from perforated ascending colon cancer.

The Gulf journal of oncology·2010

Same author

A stability-indicating first-derivative spectrophotometric assay of acetazolamide and its use in dissolution and kinetic studies.

Journal of clinical pharmacy and therapeutics·1993

Same author

The diagnostic significance of the indirect haemagglutination test in amaebiasis in children.

Journal of the Egyptian Society of Parasitology·1982

Search research articles

Related Experiment Videos

One patient, two lymphomas, three primaries.

A Eshra¹, A Al-Hendal, M Al Enezi

¹Department of Surgery, Sabah Hospital, Kuwait. aeshra2@yahoo.com

The Gulf Journal of Oncology

|July 6, 2010

Summary

This summary is machine-generated.

This case report details an extremely rare instance of three distinct primary gastrointestinal cancers occurring simultaneously. The study highlights the diagnostic challenges and importance of integrated methods for identifying these synchronous neoplasms.

Related Experiment Videos

Area of Science:

Gastroenterology
Oncology
Pathology

Background:

Synchronous primary neoplasms in the gastrointestinal tract are uncommon.
Collision tumors, where two distinct tumors arise at the same site, are exceptionally rare.

Observation:

A unique case involving a true collision tumor in the ascending colon, comprising marginal zone lymphoma and moderately differentiated adenocarcinoma.
A third synchronous primary neoplasm, a follicular lymphoma, was identified in the terminal ileum.

Findings:

The diagnosis was established through a comprehensive approach including clinical history, radiological and endoscopic investigations, histological examination, and immunohistochemistry.
This case represents three synchronous primary neoplasms within the gastrointestinal tract, with two colliding in the colon.

Implications:

Accurate diagnosis of multiple synchronous gastrointestinal neoplasms requires a multidisciplinary approach.
Understanding these rare collision tumors is crucial for appropriate patient management and treatment strategies.